Videos

Bob Cathcart, AiM Medical Robotics - Studio Interview | LSI Europe ‘22

AiM Medical Robotics is developing a portable MRI compatible surgical robot for use in the OP and MRI suite. The system is being designed for the treatment of functional brain disorders (e.g. epilepsy, Parkinson's disease).

Corporate Venture Capital & Strategic Investors: Current Priorities & Targets

What are Strategics looking for, right now, and what's the best way (and when) to access them.

Paul Russo, Kyto - Medtech Investments | LSI Europe '22

Paul Russo, Chairman & CEO of Kyto Technology & Life Science, was a presenter at the LSI Europe ‘22 Emerging Medtech Summit. KYTO is a Silicon Valley-based investment company focused on creating an ETF-like vehicle of diversified and thoroughly vetted start-ups thus defining an entirely new non-correlated asset class.

Chems Hachani, ECLEVAR - Med Device & IVD Manufacturer | LSI Europe '22

ECLEVAR supports medical devices and IVD manufacturer in the MDR and IVDR transition. Their team works as an extension team of medical affairs and regulatory affairs sponsor.

Eric Dy, Bloomlife - Personalized Prenatal Care | LSI Europe '22

Bloomlife is a women’s health company solving the most significant yet underserved global challenges today in maternal health.

Jonathan Berent, NextSense - NextSense | LSI Europe '22

NextSense is a developer of a real-world monitoring solution to obtain insights into brain health. The company's platform collects longitudinal electroencephalogram (EEG) data from biosensing earbuds that can be worn throughout the day and night.

Sadeq Ali, AccurKardia - Analyzing ECG Data in Real Time | LSI Europe '22

AccurECG is cloud-based web application that is compatible with holter monitors and consumer wearables that collects and analyzes ECG data in real-time using artificial intelligence.

Amos Ziv, CardiaCare - Studio Interview | LSI Europe ‘22

Founder & CSO, Amos Ziv and CardiaCare are developing a closed-loop neuromodulation device for the monitoring and prevention of atrial fibrillation.

Jorge Presa, Cyber Surgery - Studio Interview | LSI Europe ‘22

CEO, Jorge Presa and Cyber Surgery are developing a high precision surgical robot for spinal surgery.

Richard Ljuhar, ImageBiopsy Lab - Studio Interview | LSI Europe ‘22

CEO, Richard Ljuhar and ImageBiopsy Lab are developing a portfolio of radiographic image analysis software solutions that utilize artificial intelligence to turn data into diagnostic evidence.

Lothar Krinke, Newronika - Studio Interview | LSI Europe ‘22

CEO, Lothar Krinke and Newronika are developing AlphaDBS, a closed-loop deep brain neuromodulation system for the management of symptoms due to Parkinson's disease.

Jonathan Balfour, Panaxium - Studio Interview | LSI Europe ‘22

CFO & COO, Jonathan Balfour and Panaxium aim to make "untreatable" debilitating neurological conditions treatable via the use of precision bioelectronic devices that target specific cellular behaviors at the microscale.

Nick Talamantes, Senior Director of Market Intelligence at LSI | Medtech Pro, Powered by LSI

Medtech Pro provides trusted data and insights in an intuitive software platform to improve decision-making for everyone, from startups and strategics to investors and insiders.

Kim Vanderlinden, Early Detection - Studio Interview | LSI Europe ‘22

CEO, Kim Vanderlinden and Early Detection have developed a test to detect an altered sugar associated only with precancerous and cancerous tissue. The test can be delivered at the point-of-care and provides in-office results for patients and providers.

Peter Kassel, HealthySole - Studio Interview | LSI Europe ‘22

CEO, Peter Kassel and HealthySole are the pioneer and technology leader in reducing the pathogen load in settings where pristine environments are required.

Pierre-Francois Migeotte, HeartKinetics - Studio Interview | LSI Europe ‘22

CEO & Co-Founder, Pierre-Francois Migeotte and HeartKinetics are combining seismocardiography and ballistocardiography techniques to remotely measure cardiac vital signs.

Ruben de Francisco, Onera Health - Studio Interview | LSI Europe ‘22

CEO, Ruben de Francisco and Onera Health are developing diagnostic and monitoring solutions to help people with sleep-related ailments.

Piotr Wygocki, MIM Solutions - Studio Interview | LSI Europe ‘22

CEO, Piotr Wygocki and MIM Solutions are using artificial intelligence and machine learning to address the worldwide fertility disorder occurring in an increasing number of countries.

Mike Karim, Oxford Endovascular - Studio Interview | LSI Europe ‘22

CEO, Mike Karim and Oxford Endovascular are developing OxiFlow, a next-generation flow-diverter to reduce the risk of complications and ruptures in patients with intracranial aneurysms

Brian Thornes, X-Bolt Trauma Therapeutics - Studio Interview | LSI Europe ‘22

CEO, Brian Thornes and X-Bolt Trauma Therapeutics are developing next-generation devices for use during trauma surgeries. Key to the company's portfolio of orthopedic products are its expanding bolt design and the ability to easily reverse and remove implanted devices.

John von Benecke, Locate Bio - Studio Interview | LSI Europe ‘22

Locate Bio's orthobiologic products leverage Locate Bio's expertise in programmed drug release and instructive tissue scaffolds to enhance the tissue repair process.

John Wong, Fluid Biomed - Studio Interview | LSI Europe ‘22

Fluid Biomed is a VC-backed pre-clinical medical device start-up that has developed the world’s first bio-resorbable stent to cure brain aneurysms.

Marc Giroux, Kurve Therapeutics - Studio Interview | LSI Europe ‘22

CEO, Marc Giroux and Kurve Therapeutics bring a breakthrough approach to treat CNS disorders like Mild Cognitive Impairment, Alzheimer's, and Parkinson's.

FundamentalVR | Richard Vincent, Founder & CEO

Accelerating surgical capability for life science businesses via precision VR simulation.

Proximie | Nadine Hachach-Haram, Founder & CEO

A secure, complete software solution which expands surgical collaboration enabling surgeons to share expertise using augmented reality tools before, during and after surgery.

Facible Biodiagnostics | Steven Burden, CEO

Facible Biodiagnostics is leading the diagnostic testing revolution through our mission to provide hospital-grade diagnostic tests to everyone, everywhere.

HealthySole | Peter Kassel, CEO

HealthySole is the pioneer and technology leader in reducing the pathogen load in settings where pristine environments are required: hospitals, compounding pharmacies, pharmaceutical R&D and manufacturing, food handling, and even EMS and law enforcement.